Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...
Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback